Raymond James Financial Services Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $3.79M | Buy |
84,301
+1,678
| +2% | +$75.5K | 0.01% | 1382 |
|
|
2024
Q2 | $3.45M | Buy |
82,623
+16,791
| +26% | +$701K | ﹤0.01% | 1356 |
|
|
2024
Q1 | $3M | Buy |
65,832
+3,085
| +5% | +$140K | ﹤0.01% | 1427 |
|
|
2023
Q4 | $2.9M | Buy |
62,747
+5,203
| +9% | +$241K | ﹤0.01% | 1368 |
|
|
2023
Q3 | $2.34M | Buy |
57,544
+19,541
| +51% | +$795K | ﹤0.01% | 1412 |
|
|
2023
Q2 | $1.84M | Buy |
38,003
+4,546
| +14% | +$220K | ﹤0.01% | 1553 |
|
|
2023
Q1 | $1.65M | Buy |
33,457
+8,243
| +33% | +$406K | ﹤0.01% | 1601 |
|
|
2022
Q4 | $1.28M | Buy |
25,214
+3,311
| +15% | +$168K | ﹤0.01% | 1685 |
|
|
2022
Q3 | $1.1M | Sell |
21,903
-888
| -4% | -$44.6K | ﹤0.01% | 1749 |
|
|
2022
Q2 | $1.11M | Buy |
+22,791
| New | +$1.11M | ﹤0.01% | 1760 |
|
|
2022
Q1 | – | Sell |
-3,559
| Closed | -$283K | – | 3297 |
|
|
2021
Q4 | $283K | Sell |
3,559
-591
| -14% | -$47K | ﹤0.01% | 2751 |
|
|
2021
Q3 | $368K | Buy |
+4,150
| New | +$368K | ﹤0.01% | 2554 |
|